Takayuki Kawano Selected Research

Vanadates (Orthovanadate)

9/2006	Sodium orthovanadate enhances proliferation of progenitor cells in the adult rat subventricular zone after focal cerebral ischemia.
5/2006	Therapeutic time window and dose dependence of neuroprotective effects of sodium orthovanadate following transient middle cerebral artery occlusion in rats.
9/2003	Neuroprotective effect of postischemic administration of sodium orthovanadate in rats with transient middle cerebral artery occlusion.
8/2002	Decreased akt activity is associated with activation of forkhead transcription factor after transient forebrain ischemia in gerbil hippocampus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takayuki Kawano Research Topics

Disease

6	Brain Injuries (Brain Injury) 09/2017 - 08/2003
6	Ischemia 01/2016 - 08/2002
4	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2020 - 03/2011
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016 - 09/2003
3	Aneurysm (Aneurysms) 04/2021 - 01/2012
3	Stroke (Strokes) 12/2017 - 05/2004
3	Neoplasms (Cancer) 01/2014 - 07/2005
3	Brain Ischemia (Cerebral Ischemia) 02/2012 - 07/2005
2	Infarction (Infarctions) 04/2021 - 05/2006
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2019 - 03/2011
2	Brain Edema (Cerebral Edema) 09/2017 - 12/2015
2	Inflammation (Inflammations) 01/2016 - 07/2014
2	Pathologic Constriction (Stenosis) 12/2012 - 01/2011
1	Spinal Cord Diseases 02/2022
1	Hematoma 09/2021
1	Hypothermia 09/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2021
1	Blood Vessel Dissection 04/2021
1	Intracranial Vasospasm 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2019
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2019
1	Rupture 01/2019
1	Brain Neoplasms (Brain Tumor) 12/2017
1	CADASIL 08/2017
1	Encephalitis (Encephalitis, Rasmussen) 01/2016
1	Cerebral Infarction 05/2011
1	Neutropenia 05/2011
1	Ruptured Aneurysm 03/2011
1	Cognitive Dysfunction 11/2009
1	Prolactinoma (Prolactinomas) 01/2009
1	Pituitary ACTH Hypersecretion 01/2009
1	Ischemic Stroke 02/2006
1	Hypoxia (Hypoxemia) 02/2006
1	Clear Cell Chondrosarcoma 07/2005
1	Paresis (Hemiparesis) 07/2005
1	Brain Diseases (Brain Disorder) 05/2004

Drug/Important Bio-Agent (IBA)

4	Vanadates (Orthovanadate)IBA 09/2006 - 08/2002
4	SodiumIBA 09/2006 - 08/2002
3	ProstaglandinsIBA 01/2011 - 05/2004
2	Growth Hormone (Somatotropin)IBA 01/2019 - 01/2009
2	CytokinesIBA 01/2016 - 09/2006
2	Superoxides (Superoxide)IBA 07/2014 - 08/2007
2	N-Methylaspartate (NMDA)IBA 08/2007 - 05/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2006 - 08/2003
2	Phosphotransferases (Kinase)IBA 08/2006 - 08/2002
2	Neuroprotective AgentsIBA 05/2006 - 09/2003
2	EnzymesIBA 02/2006 - 05/2004
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2006 - 05/2004
2	Fas Ligand Protein (Fas Ligand)IBA 07/2005 - 08/2002
1	SteroidsIBA 02/2022
1	BarbituratesIBA 09/2021
1	Thiamylal (Surital)FDA Link 09/2021
1	barbituric acid (barbiturate)IBA 09/2021
1	CatecholaminesIBA 01/2020
1	Sphingosine-1-Phosphate ReceptorsIBA 09/2017
1	Pharmaceutical PreparationsIBA 09/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 09/2017
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 09/2017
1	Serum Amyloid P-ComponentIBA 08/2017
1	Angiopoietin-Like Protein 2IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	InterleukinsIBA 01/2016
1	Angiopoietin-like ProteinsIBA 01/2016
1	salicylhydroxamic acid (SHAM)IBA 12/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2014
1	Rosuvastatin Calcium (Crestor)FDA Link 07/2014
1	NF-kappa B (NF-kB)IBA 07/2014
1	AcidsIBA 01/2014
1	Polyglactin 910IBA 01/2014
1	Prostaglandins AIBA 01/2014
1	Phenobarbital (Luminal)FDA Link 12/2012
1	human esRAGE proteinIBA 02/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2011
1	Cilostazol (Pletal)FDA LinkGeneric 01/2011
1	Adenosine Triphosphate (ATP)IBA 01/2011
1	Acetazolamide (Diamox)FDA LinkGeneric 11/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2007
1	Peroxynitrous Acid (Peroxynitrite)IBA 08/2007
1	Bromodeoxyuridine (BrdU)IBA 09/2006
1	Serine (L-Serine)FDA Link 08/2006
1	Oxygen (Dioxygen)IBA 02/2006
1	Glucose (Dextrose)FDA LinkGeneric 02/2006
1	VimentinIBA 07/2005
1	S100 Proteins (S 100 Protein)IBA 07/2005
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2004

Therapy/Procedure

3	Therapeutics 09/2021 - 01/2011
2	Craniotomy 09/2021 - 07/2005
1	Decompression 09/2021
1	Conservative Treatment 04/2021
1	Ligation 04/2021
1	Denervation 01/2020
1	Cerebral Revascularization 07/2019
1	Radiotherapy 01/2019
1	Cranial Irradiation 12/2017
1	Lasers (Laser) 08/2017
1	Catheters 01/2012
1	Drug Therapy (Chemotherapy) 05/2011
1	Aftercare (After-Treatment) 11/2009
1	Surgical Amputation (Amputations) 07/2005